Your browser doesn't support javascript.
Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer.
Mack, Philip C; Gomez, Jorge E; Rodilla, Ananda M; Carreño, Juan Manuel; Hsu, Chih-Yuan; Rolfo, Christian; Meshulami, Noy; Moore, Amy; Brody, Rachel I; King, Jennifer C; Treatman, Jacquelyn; Lee, Sooyun; Raskin, Ariel; Srivastava, Komal; Gleason, Charles R; de Miguel-Perez, Diego; Tcheou, Johnstone; Bielak, Dominika; Acharya, Rashmi; Gerber, David E; Rohs, Nicholas; Henschke, Claudia I; Yankelevitz, David F; Simon, Viviana; Minna, John D; Bunn, Paul A; García-Sastre, Adolfo; Krammer, Florian; Shyr, Yu; Hirsch, Fred R.
  • Mack PC; Center for Thoracic Oncology, Tisch Cancer Institute and Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Gomez JE; Center for Thoracic Oncology, Tisch Cancer Institute and Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Rodilla AM; Center for Thoracic Oncology, Tisch Cancer Institute and Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Carreño JM; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Hsu CY; Department of Biostatistics, Vanderbilt University, Nashville, TN, USA.
  • Rolfo C; Center for Thoracic Oncology, Tisch Cancer Institute and Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Meshulami N; Center for Thoracic Oncology, Tisch Cancer Institute and Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Moore A; LUNGevity Foundation, Bethesda, MD, USA.
  • Brody RI; Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • King JC; GO2 Foundation for Lung Cancer, Washington, DC, USA.
  • Treatman J; Center for Thoracic Oncology, Tisch Cancer Institute and Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Lee S; Center for Thoracic Oncology, Tisch Cancer Institute and Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Raskin A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Srivastava K; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Gleason CR; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • de Miguel-Perez D; Center for Thoracic Oncology, Tisch Cancer Institute and Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Tcheou J; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Bielak D; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Acharya R; GO2 Foundation for Lung Cancer, Washington, DC, USA.
  • Gerber DE; Hamon Center for Therapeutic Oncology Research, Departments of Internal Medicine and Pharmacology UT Southwestern Medical Center, Dallas, TX, USA.
  • Rohs N; Center for Thoracic Oncology, Tisch Cancer Institute and Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Henschke CI; Diagnostic, Molecular and Interventional Radiology, Mount Sinai Health System, New York, NY, USA.
  • Yankelevitz DF; Diagnostic, Molecular and Interventional Radiology, Mount Sinai Health System, New York, NY, USA.
  • Simon V; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount S
  • Minna JD; Hamon Center for Therapeutic Oncology Research, Departments of Internal Medicine and Pharmacology UT Southwestern Medical Center, Dallas, TX, USA.
  • Bunn PA; Department of Internal Medicine, University of Colorado Cancer Center, Denver, CO, USA.
  • García-Sastre A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount S
  • Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at
  • Shyr Y; Department of Biostatistics, Vanderbilt University, Nashville, TN, USA.
  • Hirsch FR; Center for Thoracic Oncology, Tisch Cancer Institute and Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: fred.hirsch@mssm.edu.
Cancer Cell ; 40(6): 575-577, 2022 06 13.
Article in English | MEDLINE | ID: covidwho-1797106
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Lung Neoplasms Type of study: Prognostic study Topics: Vaccines / Variants Limits: Humans Language: English Journal: Cancer Cell Journal subject: Neoplasms Year: 2022 Document Type: Article Affiliation country: J.ccell.2022.04.012

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Lung Neoplasms Type of study: Prognostic study Topics: Vaccines / Variants Limits: Humans Language: English Journal: Cancer Cell Journal subject: Neoplasms Year: 2022 Document Type: Article Affiliation country: J.ccell.2022.04.012